Avapritinib
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 248 publications
Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.
Journal: medRxiv : the preprint server for health sciences
Published: February 12, 2026
Journal Club: Mastocytosis: across the spectrum: pathobiology, clinical evaluation, and evolving therapies.
Journal: European journal of dermatology : EJD
Published: January 29, 2026
Skeletal Involvement in Systemic Mastocytosis: Pathophysiology, Clinical Management, Standards of Care, and Novel Therapeutic Strategies.
Journal: Cells
Published: January 15, 2026
Avapritinib for targeting KIT D816V-mutated acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplant with extramedullary and central nervous system involvement.
Journal: Annals of hematology
Published: January 15, 2026
Refractory cutaneous symptoms in systemic mastocytosis.
Journal: JAAD case reports
Published: January 15, 2026
Treatment with interferon α-1b, interleukin-2, and thalidomide for persistent RUNX1::RUNX1T1 in a patient with KIT-mutated acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a case report and literature review
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: December 17, 2025
The Evolving Role of Second- and Third-Generation Tyrosine Kinase Inhibitors in Gastrointestinal Malignancies: Advances in Targeted Therapy with Sunitinib, Regorafenib, and Avapritinib.
Journal: Journal of clinical medicine
Published: December 01, 2025
Nemolizumab as an Alternative Therapeutic Option for Indolent Systemic Mastocytosis.
Journal: Cureus
Published: November 25, 2025
Cytoreduction is a Valid Option for Treatment and Prevention of Anaphylaxis in Systemic Mastocytosis: Case Report and Literature Review.
Journal: Clinical reviews in allergy & immunology
Published: November 16, 2025
Case report: A case of mast cell leukemia treated with avapritinib: from diagnostic challenge to transplantation.
Journal: Frontiers in oncology
Published: November 14, 2025
Lampson B, Zakharyan A, Shimony SO, Shi H, Deangelo D. Analysis of avapritinib clinical trial data generates a highly accurate predictive model for advanced systemic mastocytosis versus indolent systemic mastocytosis based on peripheral blood testing. Blood. 2024;144(suppl 1):107.
Journal: Blood
Published: November 06, 2025
Last Updated: 04/28/2026